SCHEMBL28446202

SCHEMBL28446202

CCOC(=O)c1cnc(SC)nc1N[C@@H]1CCC[C@H](OC(=O)c2cnc(SC)nc2N[C@@H]2CCC[C@H](O)C2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 3/20 0.53
JAK3 P52333 3/20 0.53
ALDH1A1 P00352 3/20 0.48
MAPK8 P45983 7/20 0.47
MAPK9 P45984 4/20 0.47
SYK P43405 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 3/20 0.45
NR2F2 P24468 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPK1 P28482 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
FOS P01100 1/20 0.45
JUN P05412 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30873297 0.94 JAK1 (0.59) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL14657356 0.94 JAK1 (0.59) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL28446204 0.90 JAK1 (0.55) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL14657264 0.89 ALDH1A1 (0.56) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL30873366 0.89 ALDH1A1 (0.56) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL28447592 0.88 JAK1 (0.54) JAK1JAK3ALDH1A1MAPK8MAPK9
SCHEMBL22860692 0.86 ALDH1A1 (0.60) JAK1JAK3ALDH1A1SYKMEN1
SCHEMBL23948226 0.85 ALDH1A1 (0.59) JAK1JAK3ALDH1A1SYKMEN1
SCHEMBL29501934 0.85 ALDH1A1 (0.59) JAK1JAK3ALDH1A1SYKMEN1
SCHEMBL26159707 0.85 ALDH1A1 (0.59) JAK1JAK3ALDH1A1SYKMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111471021-A Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-07-31 CN disclosed